共 23 条
Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)
被引:102
作者:
Broomé, U
Glaumann, H
Lindström, E
Lööf, L
Almer, S
Prytz, H
Sandberg-Gertzén, H
Lindgren, S
Fork, FT
Järnerot, G
Olsson, R
机构:
[1] Huddinge Univ Hosp, Dept Gastroenterol, Stockholm, Sweden
[2] Huddinge Univ Hosp, Dept Infect Dis & Pathol, Stockholm, Sweden
[3] Malmo Univ Hosp, Dept Radiol, Malmo, Sweden
[4] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden
[5] Linkoping Univ Hosp, Dept Med, Linkoping, Sweden
[6] Univ Lund Hosp, Dept Med, S-22185 Lund, Sweden
[7] Reg Hosp Orebro, Gothenburg, Sweden
[8] Malmo Univ Hosp, Dept Gastroenterol, Malmo, Sweden
[9] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden
关键词:
ulcerative colitis;
liver transplantation;
natural history;
cholangiocarcinoma;
D O I:
10.1016/S0168-8278(02)00036-3
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Background/Aims: This study aims at describing the natural history and outcome of small duct primary sclerosing cholangitis (PSC). Methods: Thirty-two patients with small duct PSC were studied. The average time taken for diagnosis was 69 (1-168) months. The median follow-up time was 63 (1-194) months. Results: All patients including one who underwent liver transplantation because of end-stage liver disease and hepatocellular carcinoma were alive at follow-up. None developed cholangiocarcinoma. In 27 patients repeated cholangiographic examinations were done after a median time of 72 (12-192) months from first ERCP. Four developed features of large duct PSC. Conclusions: Small duct PSC rarely progresses to large bile duct PSC and it seems to have a benign course in most patients and no development of cholangiocarcinoma was found. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:586 / 589
页数:4
相关论文